D. E. Shaw & Co., Inc. - SUNESIS PHARMACEUTICALS INC ownership

Quarter-by-quarter ownership
D. E. Shaw & Co., Inc. ownership history of SUNESIS PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2017$123,000
+41.4%
29,874
+23.6%
0.00%
Q4 2016$87,000
+20.8%
24,179
+47.6%
0.00%
Q3 2016$72,00016,3770.00%
Other shareholders
SUNESIS PHARMACEUTICALS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Aisling Capital Management LP 7,600,000$9,234,0007.03%
Samsara BioCapital, LLC 3,750,000$4,556,0003.58%
CAXTON CORP 277,245$337,0000.31%
BVF INC/IL 2,287,860$2,780,0000.31%
Eventide Asset Management 5,965,455$7,248,0000.25%
Telemetry Investments, L.L.C. 197,564$240,0000.12%
NEA Management Company, LLC 1,298,274$1,584,0000.08%
RP Management, LLC 129,517$158,0000.08%
Palo Alto Investors LP 1,162,473$1,412,0000.06%
Fosun International Ltd 725,000$863,0000.06%
View complete list of SUNESIS PHARMACEUTICALS INC shareholders